Yahoo Web Search

Search results

1. • Wegovy & other GLP-1 drugs to get coverage under Medicare Part D

     AARP· 5 hours ago

     The FDA recently approved a new use for Wegovy (semaglutide), the blockbuster anti-obesity drug, to reduce the risk of heart attacks and stroke in people with cardiovascular disease who are ...

2. • 

     CVS stock plunges after earnings numbers one analyst 'did not even believe'

     Yahoo Finance· 4 hours ago

     Margins over membership In order to right-size its balance sheet in the face of more Medicare...

3. • 

     As Medicare Part D grows, so does need for fraud audits

     BenefitsPRO· 6 days ago

     CMS is required to audit the financial records of at least one-third of Part D plan sponsors...

4. • 

     A ‘slap in the face’: Retired state workers in Maryland outraged by drug plan switch

     Baltimore Sun· 11 hours ago

     Instead, Varner — a professor emeritus at the University of Maryland, College Park, who was...

5. • 

     Can you Change Your Medicare Plan Outside of Open Enrollment?

     TMJ4 Milwaukee· 6 hours ago

     Ben DeGracie is back from Sovereign Select to chat about special circumstances for those on Medicare...

6. • 

     CMS Advises Preparatory Steps for Anticipated PrEP Coverage Transition to Medicare Part B

     The National Law Review· 6 days ago

     On April 15, the Centers for Medicare & Medicaid Services (CMS) released a

7. • 

     CVS Health (CVS) Q1 2024 Earnings Call Transcript

     Motley Fool via Yahoo Finance· 4 hours ago

     We will provide updates throughout the year on these efforts. I also feel it is important to discuss our long-term outlook for Medicare Advantage. We...

8. • 

     What is the Medicare Donut Hole and What Are Your Options?

     Penny Hoarder via AOL· 4 days ago

     Medicare can feel complicated. It’s easy to get overwhelmed when sorting through pages of...

9. • 

     Pfizer stock gains 7% after earnings beat, company calls dividend 'secure'

     Yahoo Finance via AOL· 1 hour ago

     Eliquis represents nearly 14% of Pfizer’s Q1 revenue, and we recognize the uncertainty tied to the...

10. • Exelixis Inc (EXEL) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...

      GuruFocus.com via Yahoo Finance· 14 hours ago

      CABOMETYX Net Product Revenues: $376.4 million, including about $6 million in clinical trial sales. Gross to Net Deductions: 32.9% for Q1 2024, primarily due to higher Medicare</ ...